U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech

MAP Verified Summary — reported by NPR News

The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.

This story’s context record documents 7 observable dimensions — Origin, Attribution, Specificity, Timing, Framing, Context Change, and Information Relationships — as part of Media Alert Press’s context-documentation ledger. MAP does not score or rate this content. Read the full original story at NPR News →

View MAP Context →